Skip to content
  • IT | EN
  • About DAB
DAB References
  • Products→
  • DTraining→
  • Support→
  • Contact→
  • IT | EN
  • About DAB
Saman Daroo 8 – water consumption improvement

Saman Daroo 8 – water consumption improvement

The request

Saman Daroo 8 is a biotechnology organization which operates under the holding of Samen pharmaceutical company; it is the first biotechnology company in Iran and the sixth in the world that produces human recombinant factor VIII (hr FVIII).

In this center besides endeavors to develop the most efficient and long-acting FVIII, there will be attempts for improving other recombinant products and monoclonal antibodies for treating a vast spectrum of diseases such as autoimmune and neurological disorders and cancers.

The project and the relative concept to improve the efficiency of water consumption inside the main building has been designed and realised with our professional range of DAB products made in Italy:

KV (vertical multistage centrifugal pumps for high flow boosting);

K single and double impeller (centrifugal pumps for high flow boosting);

KDN, NKP-G, NKM-G (standardized centrifugal pumps for HVAC and Firefighting booster systems).

The project was implemented through the support of two main companies:

Knowledge based on Spico LTD, the exclusive partner for DAB in Iran that provide engineering support in order to improve solutions able to optimize the systems.

Diesel Pump Asia Trade Co, the exclusive representative of DAB Company in Khorasan that provide materials in line with the project requirements and after sales service support.

Download the PDF

Products and applications of the reference

Where: Iran

Applications: Heating, Air Conditioning, Water Pressure Boosting

Products: KV, K Monogirante, K Bigirante, KDN, NKM-G, NKP-G

  • IT | EN
  • Terms of use
  • Cookies
  • Privacy Policy
  • Whistleblowing

Dab Pumps Spa © Via Marco Polo, 14 Mestrino Padova - Italy Tel. +39.049.5125000 Fax +39.049.5125950
VAT No. 03675230282 - Companies Register Padova No. 328200 - Share Capital Euro €10,000,000 fully paid